Log in

ETRACS Alerian Midstream Energy Stock Forecast, Price & News

-0.20 (-0.88 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $22.53
50-Day Range
MA: $22.59
52-Week Range
Now: $22.53
Volume1,000 shs
Average VolumeN/A
Market Capitalization$45.06 million
P/E RatioN/A
Dividend Yield0.00%

Basic Details

Issuer UBS
Fund NameETRACS Alerian Midstream Energy Index ETN
Tax ClassificationExchange-Traded Note
Inception Date6/19/2020
Fund Manager

Fund Focus

Asset ClassEquity
BenchmarkAlerian Midstream Energy Select Index
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$44.63 million
Average Daily Volume$0.00

ETF Expenses

Management Fee0.75%
Other Expenses0.00%
Total Expenses0.75%
Fee Waiver0.00%
Net Expenses0.75%

Administrator, Advisor and Custodian

AdvisorUBS AG (London Branch)
Transfer Agent
Lead Market Maker
-0.20 (-0.88 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMNA News and Ratings via Email

Sign-up to receive the latest news and ratings for AMNA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

ETRACS Alerian Midstream Energy (NYSEARCA:AMNA) Frequently Asked Questions

What is ETRACS Alerian Midstream Energy's stock symbol?

ETRACS Alerian Midstream Energy trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "AMNA."

How do I buy shares of ETRACS Alerian Midstream Energy?

Shares of AMNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ETRACS Alerian Midstream Energy's stock price today?

One share of AMNA stock can currently be purchased for approximately $22.53.

How big of a company is ETRACS Alerian Midstream Energy?

ETRACS Alerian Midstream Energy has a market capitalization of $45.06 million.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.